Value chain stagesInput

Products 71 to 80 of 120

Mast-MO (antibiotic wasp venom) by University of Pennsylvania’s Perelman School of Medicine
Biotech components: Animal + Bacteria + Molecule
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:40 (1 year ago)
Date last modified: 2020/12/18 14:40 (1 year ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Medusoid: Tissue-Engineered Biomimetic Jellyfish by Harvard University + Caltech
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Research + Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: N/A
Funding types: University
Industry: Health
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical (Device)
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (3 years ago)
Date last modified: 2019/09/13 11:47 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy
Market status: Under Development
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (3 years ago)
Date last modified: 2019/09/13 11:47 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy
Market status: Under Development
Organization type(s): Public Company
Product categories: Chemical + Fuel and Energy
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (3 years ago)
Date last modified: 2019/09/13 11:47 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Fuel and Energy + Chemical
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (3 years ago)
Date last modified: 2019/09/13 11:47 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy
Market status: Under Development
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (3 years ago)
Date last modified: 2019/09/13 11:47 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Chemical + Other (Industrial)
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Microbe-Derived Dielectric Fluids by Tarravia + Solazyme + Dow Chemical Company
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2019/05/15 16:13 (3 years ago)
Known funding amount: 174,900,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: SZYM (NASDAQ)
Value chain stage: Input
Biotech components: Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: No longer on the market
Organization type(s): Public Company
Product categories: Fiber
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biotech components: Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: No longer on the market
Organization type(s): Public Company
Product categories: Fiber
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input